Older adults have low knowledge of RSV disease and vaccine eligibility
Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, ...
Healio16h
RSV may elevate risk for stroke, heart failure hospitalization
Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...
After Val Kilmer’s pneumonia death, what to know about the respiratory virus
Actor Val Kilmer, 65, died of pneumonia this week, his daughter confirmed. Dr. Marc Siegel discusses common causes and risks ...
European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
GSK resolves patent lawsuit against Pfizer over RSV vaccines
By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...
Fierce Pharma3d
GSK, Pfizer resolve RSV patent feud amid vaccine market uncertainty
As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...
Pulmonology Advisor14h
How Do Coinfections Influence Disease Severity, Progression in Pediatric Viral LRTIs?
Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.
Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influenza, respiratory syncytial virus (RSV), ...
McKnight's Long-Term Care News6d
Older adults more apt to receive RSV vaccine, but uptake low in long-term care: study
Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...
European Commission Approves Pfizer’s RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...
Respiratory season ends, B.C. launching spring COVID-19 vaccination campaign
Respiratory illness season is over, British Columbia's top doctor said Friday, but the province is set to launch a spring ...
Pfizer, GSK settle patent lawsuit over RSV vaccines
Pfizer (NYSE:PFE) and GSK (NYSE:GSK) on Thursday agreed to end a patent lawsuit over claims that the former’s vaccine, ...